Pfizer (PFE) Earnings Analysis
Pfizer (PFE) has no confirmed upcoming earnings date. Trailing P/E 18.95.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PFE next report earnings?
No confirmed upcoming earnings date is currently scheduled for PFE. This page updates as the calendar is published.
PFE earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
PFE valuation and analyst view
| Trailing P/E | 18.95 |
|---|---|
| Trailing EPS | 1.316 USD |
| Price / book | 1.57 |
| Dividend yield | 6.93% |
| Market cap | 142.06B |
| Analyst consensus | Hold (15 buy / 23 hold / 1 sell) |
| Avg price target | 27 USD |
Related research pages
Frequently asked questions
When is Pfizer (PFE)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for PFE. This page updates as the calendar is published.
What is PFE's current P/E ratio and EPS?
PFE trades at a trailing P/E of 18.95 on trailing EPS of 1.316288877174486 USD.
What do analysts rate PFE?
Analyst consensus is "Hold" across 39 ratings (0 strong buy, 15 buy, 23 hold, 1 sell, 0 strong sell). Average 12-month price target: 27 USD.